There were 2,406 press releases posted in the last 24 hours and 431,964 in the last 365 days.

Zhang Investor Law Announces Securities Class Action Lawsuit Against PaySign, Inc. – PAYS

NEW YORK, April 15, 2020 (GLOBE NEWSWIRE) -- Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of PaySign, Inc. (NASDAQ: PAYS) between March 12, 2019 and March 15, 2020, inclusive (the “Class Period”).

If you wish to serve as lead plaintiff, you must move the Court no later than May 18, 2020.  A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. 

To join the class action, http://zhanginvestorlaw.com/join-action-form/?slug=paysign-inc&id=2223 call Sophie Zhang, Esq. toll-free at 800-991-3756 or email info@zhanginvestorlaw.com for information on the class action.

如果您想加入这个集体诉讼案,请在这里提交您的信息。http://zhanginvestorlaw.com/join-action-form/?slug=paysign-inc&id=2223

According to the lawsuit, the company failed to disclose and/or misstated:  (1) PaySign’s internal control over financial reporting was not effective; (2) PaySign’s information technology general controls were not effective; and (3) as a result, defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

A class has not been certified.  You may retain counsel of your choice.  You may take no action at this time and be an absent class member.  Your ability to obtain a recovery is not dependent upon being a lead plaintiff.  

Zhang Investor Law represents investors worldwide.  Attorney Advertising.  Prior results do not guarantee similar outcomes.

Zhang Investor Law P.C.
99 Wall Street, Suite 232
New York, New York 10005
info@zhanginvestorlaw.com
tel: (800) 991-3756

Primary Logo

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.